INTRODUCTION
Intramuscular (i.m.) injection of DNA plasmids encoding protein antigens has been demonstrated to induce MHC class I-rectricted cytotoxic T-lymphocyte (CTL) and antibody (Ab) responses, and to protect against subsequent challenge in certain disease models, with for inducing proteCtive CTL responses (1) (2) (3) . We previously demonstrated the efficacy of DNA vaccines in vivo by showing that i.m. injection of mice with plasmid DNA encoding nucleoprotein (NP) from influenza virus A/PR/8/34 (HINI) provided protection against cross-strain challenge with A/HK/68 (H3N2) (3) . CTL responses specific for an H-2Kd-restricted epitope (residues has been established that CD8+ CTL recognition generally requires intracellular processing of endogenously synthesized proteins for presentation of antigenic peptides by MHC class I molecules (6, 7) . The cellular mechanism that accounts for the class I-restricted processing and presentation of antigens synthesized after i.m. DNA immunization, however, has not been elucidated.
Several lines of evidence suggested that muscle cells may play a role in the generation of CTL after i.m. injection of DNA. First, when plasmid DNA encoding reporter enzymes was injected into various organs, muscles expressed higher levels of protein than did other tissues when directly injected (e.g., skin, liver, brain, etc.) (8) . Second, i.m. injection of NP DNA yielded better cell-mediated protection against cross-strain virus challenge than did intradermal injection of the same plasmid (1) . Finally, transplantation of myoblasts stably transfected with DNA encoding NP was able to induce CTL responses and protective cross-strain immunity in histocompatible mice (4) . In this latter experiment, production of NP antigen should occur exclusively in muscle cells. Thus, NP synthesis by myocytes alone appears to be sufficient for the induction of protective CTL responses. These observations raised the possibility that myocytes could function as antigen-presenting cells (APCs) for induction of MHC class I-restricted CTL responses by DNA immunization. Although myocytes can present antigen in the context of MHC molecules as shown by their ability to present antigens to T cells in culture (9) and to serve as targets for MHC class I-restricted CTL in vitro (4), they lack adhesion/costimulatory molecules (10) thought to be required for priming CTL responses. Therefore, other mechanisms, such as direct transfection of other cell types (e.g., BM-derived professional APCs) and antigen transfer from antigen-producing myocytes to bone marrow (BM) -derived APCs, as implicated in "cross-priming" experiments (1 1), must be considered.
The 
MATERIALS AND METHODS

DNA Constructs
The expression vector used in the study, VlJa, was derived from the vector V1J, which has been described previously (12) . Briefly, it is a pUC19-based plasmid that contains the human cytomegalovirus immediate early gene enhancer and promoter, the intron A sequence, multiple restriction sites (Bglll, KpnI, EcoRV, EcoRI, Sall, and NotI) for cloning the gene of interest, and the bovine growth hormone polyadenylation signal sequence. The NP gene from influenza virus A/PR/8/34 (H1N1) was cloned into the Bglll and Sall sites of VlJa vector (named NP DNA). Generation of NPmut DNA is described elsewhere (5 Spleen cells were cultured to generate effector CTL as previously described (3, 5) . Spleen cell cultures were maintained in RPMI 1640 media supplemented with 10% FBS, 2 mM L-glutamine, 5 X 10-5 M /3-mercaptoethanol, 25 ,ug/ml pyruvic acid, 100 U/ml penicillin, 100 Amg/ml streptomycin, 5 
Cytotoxicity Assay
The cytotoxicity assays were performed as described previously (3, 5) . Briefly, target cells labeled with Na5'CrO4 (Amersham Life Sciences, Arlington Heights, IL) were either infected with influenza virus A/Victoria/73 (H3N2), or pulsed with synthetic peptides at 5-to 10-,uM concentration. The target cells were then mixed with CTL at designated effector:target cell ratios in 96-well plates, and incubated at 37°C for 4 hr in the presence of 5% CO2. A 20-Al sample of supernatant from each cell mixture was counted to determine the amount of 5"Cr released from target cells. The percentage of specific lysis was calculated using the formula below:
where E represents the average cpm released from target cells in the presence of effector cells, S is the spontaneous cpm released in the presence of media only, and M is the maximum cpm released in the presence of 5 % SDS or 2% Triton x-100.
RESULTS
Bone Marrow Chimeric Mice Three CTL epitopes of influenza NP restricted by H-2Kd, H-2Db, and H-2Kk molecules, respectively, are shown in Fig. IA , and the concept of an Fl BM chimera is depicted in Fig. 1B To control for the possibility that the lack of the H-2Db-restricted response in NP DNA-immunized H-2d -> H-2dxb chimeras was a result of antigenic competition between the H-2Kd epitope and the H-2Db epitope in antigen processing and presentation at intra-or intercellular levels, we generated a full-length mutant version of the NP DNA vector in which the two putative anchor residues for the NP147-155 CTL epitope were altered (20, 21) (Fig. iB) . This mutant NP vector, termed NPmut DNA, though unable to induce the H-2Kd-restricted 147-155-specific response in BALB/c mice, was capable of inducing an H-2Db-restricted 366-374-specific response in C57BL/6 mice (5). Upon immunization with NPmut DNA, the H-2Kd-restricted 147-155-specific response was not detectable in either H-2d > H-2dxb or H-2dxb -, H-2 dxb chimeras, whereas the H-2Db-restricted 366-374-specific response was observed in both H-2b -> H-2dxb and H-2dXb r> H-2 dXb mice (Fig. 4,A and B) . However, no CTL response could be detected against the H-2Db peptide in H-2d -> H-2dxb chimeras even when mice were immunized with NPmut DNA in which the functional presentation of the H-2Kd-restricted 147-155 epitope was absent. Thus, the lack of the H-2Db-restricted CTL response in H-2d r H-2dxb chimeras could not be attributed to immunodominance of the H-2Kd-restricted NP147-155 epitope, indicating that presentation following NP DNA immunization was indeed restricted to the haplotype of the BM donor cells and, hence, the APCs were BMderived cells rather than myocytes. (Fig. 3A) .
Transfer of Antigen from Myocytes
Previous studies from our laboratory showed that i.m. or i.p. transplantation of viable myoblasts stably transfected with the NP gene was sufficient to induce CTL responses. Intraperitoneal (i.p.) transplantation of NP DNA-transfected myoblasts of the H-2k haplotype was able to prime both H-2d-and H-2k-restricted CTL responses in DBA/2 X C3H Fl (H-2dxk) mice (4 (25, 26) and the potential role of other cells, such as the myocytes, was not addressed (25) (26) (27) . However, this study demonstrates definitively that professional antigen-presenting cells, i.e., BM-derived APCs, are required for CTL priming. We have supported this observation by demonstrating that the H-2b H-2dxb BM chimeras used in our studies possessed a T cell receptor repertoire capable of responding to antigens in the context of either parental MHC haplotype. In addition, we ruled out the possibility of antigenic competition between the dominant CTL epitopes of the H-2d and H-2b haplotypes. Both of these controls are essential for validation of the system and necessary for proving that APCs are required. Furthermore, our study demonstrated that it is not necessary for professional APCs to be transfected by injected DNA in order for the induction of CTL to occur, since we showed that antigen synthesized in situ by myocytes was presented by professional APCs for induction of MHC class I-restricted CTL responses. Finally, we also showed that antigen presentation leading to CTL responses during viral infection was likewise restricted to the MHC haplotype of professional APCs.
Since immunization with soluble recombinant NP protein did not induce MHC class Irestricted CTL responses or protection against cross-strain virus challenge (4, 28) , the molecular form of NP or the means by which NP is transferred might be different from the soluble NP protein when injected. The antigen transfer we observed after myoblast transplantation provides further evidence for MHC class I-associated antigen processing and presentation such as the proposed mechanism known as cross-priming (11, 13, 29, 30) . This transfer of antigen may be an important alternative to the generally accepted rule that only endogenously produced antigens will be processed and presented via the MHC class I-restricted pathway (6, 7) . Although the observation that priming of CTL in influenza virus-infected chimeras depends on antigen presentation by the donor BM-derived APCs and may reflect infection of APCs, it is also possible that transfer of antigen from the infected respiratory epithelial cells occurs in a manner analogous to the transfer from myocytes to APCs. The efficacy of induction of cross-strain protective immunity by DNA 
